Jean Campbell
Vice President of Membership Development,
National Organization for Rare Disorders (NORD)
Danbury, Connecticut, United States

Corey Casper, MD, MPH
Associate Professor of Medicine, Allergy & Infectious Diseases
Adjunct Associate Professor, Epidemiology and Global Health
University of Washington
Assistant Member, Vaccine and Infectious Diseases Institute
Director, Uganda Program on Cancer & Infectious Diseases
Fred Hutchinson Cancer Research Center
Seattle, Washington, United States

David Golub
Vice President
Mark Krueger and Associates, Inc.
New York City, New York, United States

Billy Wayne Hook, Jr.
Castleman’s Disease Patient
Patient Advocate, MD Anderson Hospital
Texas, United States

Jim Johnston
Founder and Executive Director
International Castleman’s Disease Organization
Castleman’s Disease Patient Advocate
Santa Fe, New Mexico, United States

Razelle Kurzrock, M.D., FACP
Chair and Professor
Department of Investigational Cancer Therapeutics
[A Phase I Program]
Anderson Clinical Faculty Chair for Cancer Treatment and Research
Division of Cancer Medicine
University of Texas M.D. Anderson Cancer Center
Houston, Texas, United States

Gregory Pacheco
Castleman’s Disease Patient,
Campaigner for CD Research
Pasa Robles, California, United States

H. Miles Prince MBBS (Hons) MD, MRACMA, FRACP, FRCPA
Director, Centre for Blood Cell Therapies
Peter MacCallum Cancer Centre
Melbourne, Victoria, Australia

Jean-Francois Rossi, MD, PhD
Head of Department, Haematology and Medical Oncology,
CHU Saint-Eloi
Montpellier, France

Guido Tricot, MD, PhD
Director, Stem Cell Transplant and Myeloma Program
University of Utah School of Medicine
Salt Lake City, Utah, United States

Frits van Rhee, MD, PhD, FRCPath
Director of Immunotherapy and Allogeneic Transplantation, 
Myeloma Institute for Research and Therapy, 
University of Arkansas Medical Sciences
Little Rock, Arkansas, United States